Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-05-10Clinical Trial Update: Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection
This clinical trial update examines how Th1/Th2 balance and monokine responses may influence the risk of renal transplant rejection.
-
CLINICAL_TRIALS trial_result · 2007-05-09Clinical Trial Update: Autonomic Imbalance and 24-h Blood Pressure Change in Patients With Chronic Renal Disease
A completed clinical trial examining autonomic imbalance and 24-hour blood pressure changes in patients with chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2007-05-09Clinical Trial Update: Effects of Atorvastatin Versus Probucol on Small Dense LDL [Phase 4]
Phase 4 clinical trial comparing atorvastatin and probucol on small dense LDL levels in patients with chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2007-04-25Clinical Trial Update: Short Term Effects of FX Dialysers on QOL and Inflammation [Phase 4]
Phase 4 trial evaluating the short-term effects of FX dialyzers on quality of life and inflammation in chronic kidney disease; the study has…
-
CLINICAL_TRIALS trial_result · 2007-04-24Clinical Trial Update: Effects of Creatine Supplementation on Renal Function [NA]
This clinical trial evaluated the effects of creatine supplementation on renal function in individuals with renal insufficiency; the study s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-04-18Clinical Trial Update: A Randomized Control Trial Comparing Single vs. Multiple Application of Lidocaine Analgesia Prior to Urethral Catheterization Procedures [Phase 2]
A Phase 2 randomized trial compares single versus multiple applications of lidocaine analgesia before urethral catheterization; the study ha…
-
FDA approval · 2007-03-28FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for furosemide by Hikma Pharmaceuticals USA Inc., approving regulatory action on an existing generic…
-
CLINICAL_TRIALS trial_result · 2007-03-23Clinical Trial Update: Correlation of Urinary Kallikrein With Cytokines, Proteinuria and Renal Function in Chronic Renal Disease Patients
A completed clinical trial evaluates whether urinary kallikrein levels correlate with cytokines, proteinuria, and renal function in patients…
-
CLINICAL_TRIALS research · 2007-03-13Clinical Trial Update: Multifaceted Intervention to Improve Prescribing in Patients With Chronic Kidney Disease [NA]
This clinical trial update describes a multifaceted intervention aimed at improving prescribing practices for patients with chronic kidney d…
-
CLINICAL_TRIALS research · 2007-03-01Clinical Trial Update: Albumin Dialysis in End-Stage Renal Disease: Detoxification Capacity and Impact on Vascular Endothelial Function [Phase 1, Phase 2]
A Phase 1/2 trial evaluating albumin dialysis in end-stage renal disease to assess detoxification capacity and effects on vascular endotheli…
-
CLINICAL_TRIALS research · 2007-02-21Clinical Trial Update: Relation Between Polymorphism in Genes Related to Kidney Disease and Renal Manifistations in Fabry Disease
Completed clinical trial examining how genetic polymorphisms related to kidney disease influence renal manifestations in Fabry disease.
-
FDA approval · 2007-02-09FDA Approved: VENOFER — Supplemental Application (Fresenius Medical Care Holdings, Inc.)
The FDA approved a supplemental application for VENOFER (iron sucrose) submitted by Fresenius Medical Care Holdings, Inc.
-
CLINICAL_TRIALS trial_result · 2007-02-07Clinical Trial Update: Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia [Phase 2]
Phase 2 trial update assessing the efficacy and tolerability of ILY101 in dialysis patients with hyperphosphatemia.
-
CLINICAL_TRIALS trial_result · 2007-02-01Clinical Trial Update: Improved Estimation of GFR by Cystatin C in Preventing Contrast Induced Nephropathy by NAC or Zn [NA]
Clinical trial update on using cystatin C–based estimation of glomerular filtration rate to prevent contrast-induced nephropathy with N-acet…
-
CLINICAL_TRIALS research · 2007-01-09Clinical Trial Update: Effects of Cognitive-Behavioral Therapy on Sleep Disturbance in Peritoneal Dialysis Patients [Phase 3]
Phase 3 clinical trial update assessing the effect of cognitive-behavioral therapy on sleep disturbance in peritoneal dialysis patients.
-
CLINICAL_TRIALS trial_result · 2006-12-22Clinical Trial Update: Prophylactic Effect of Nifedipine on Further Decline in Renal Function in Patients Undergoing Open-Heart Surgery [Phase 4]
A Phase 4 trial evaluating the prophylactic effect of nifedipine on preserving renal function in patients undergoing open-heart surgery has …
-
CLINICAL_TRIALS trial_result · 2006-12-13Clinical Trial Update: Ergocalciferol in Chronic Kidney Disease
A completed clinical trial examining ergocalciferol (vitamin D2) in patients with chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2006-11-27Clinical Trial Update: NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization [Phase 4]
Phase 4 trial comparing N-acetylcysteine versus ascorbic acid to prevent contrast-induced nephropathy in patients with renal insufficiency u…
-
CLINICAL_TRIALS trial_result · 2006-11-03Clinical Trial Update: Citrate Anticoagulation vs. Heparin-Coated Dialyzers [Phase 3]
A Phase 3 trial comparing citrate anticoagulation with heparin-coated dialyzers in dialysis patients has completed.
-
FDA approval · 2006-11-01FDA Approved: HUMATROPE — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMATROPE (somatropin) submitted by Eli Lilly and Company.
-
FDA approval · 2006-10-26FDA Approved: HUMATROPE — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMATROPE (somatropin) submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2006-10-26Clinical Trial Update: Open Label Trial to Establish the Equivalence Between ANDY-Disc® and Ultrabag® in Patients on CAPD. [Phase 4]
A completed open-label Phase 4 trial evaluated whether ANDY-Disc and Ultrabag are equivalent in patients undergoing continuous ambulatory pe…
-
CLINICAL_TRIALS trial_result · 2006-10-17Clinical Trial Update: Very Low Protein Diet or Dialysis in Uremic Elderly? [Phase 4]
This Phase 4 trial, conducted in elderly patients with uremia, compared a very low protein diet to dialysis and has completed, reporting sur…
-
CLINICAL_TRIALS trial_result · 2006-10-06Clinical Trial Update: Anti-Oxidant Therapy In Chronic Renal Insufficiency (ATIC) Study [Phase 4]
Phase 4 clinical trial of an antioxidant therapy in chronic kidney disease was terminated.
-
CLINICAL_TRIALS research · 2006-10-04Clinical Trial Update: Prevalence of Chronic KIdney Disease in Hypertensive Patients
This clinical trial update reviews the prevalence of chronic kidney disease among patients with hypertension.